Babalola CP - Search Results

1

Pharmacokinetic Parameters of Quinine in Healthy Subjects and in Patients with Uncomplicated Malaria in Nigeria: Analysis of Data using a Population Approach.

Adehin A, Igbinoba SI, Soyinka JO, Onyeji CO, Babalola CP, Bolaji OO. Adehin A, et al. Among authors: babalola cp. Curr Ther Res Clin Exp. 2019 Sep 12;91:33-38. doi: 10.1016/j.curtheres.2019.100567. eCollection 2019. Curr Ther Res Clin Exp. 2019. PMID: 31871506 Free PMC article.

2

Characterization of the principal metabolite of quinine in human urine by 1H-n.m.r. spectroscopy.

Bolaji OO, Babalola CP, Dixon PA. Bolaji OO, et al. Among authors: babalola cp. Xenobiotica. 1991 Apr;21(4):447-50. doi: 10.3109/00498259109039484. Xenobiotica. 1991. PMID: 1897244

3

Column liquid chromatographic analysis of quinine in human plasma, saliva and urine.

Babalola CP, Bolaji OO, Dixon PA, Ogunbona FA. Babalola CP, et al. J Chromatogr. 1993 Jun 23;616(1):151-4. doi: 10.1016/0378-4347(93)80482-j. J Chromatogr. 1993. PMID: 8376486

4

Relationship between plasma and saliva quinine levels in humans.

Babalola CP, Bolaji OO, Ogunbona FA, Dixon PA. Babalola CP, et al. Ther Drug Monit. 1996 Feb;18(1):30-3. doi: 10.1097/00007691-199602000-00005. Ther Drug Monit. 1996. PMID: 8848817 Clinical Trial.

5

Pharmacokinetics of quinine in African patients with acute falciparum malaria.

Babalola CP, Bolaji OO, Ogunbona FA, Sowunmi A, Walker O. Babalola CP, et al. Pharm World Sci. 1998 Jun;20(3):118-22. doi: 10.1023/a:1008699022244. Pharm World Sci. 1998. PMID: 9618735 Clinical Trial.

6

Effects of absorption enhancers in chloroquine suppository formulations: I. In vitro release characteristics.

Onyeji CO, Adebayo AS, Babalola CP. Onyeji CO, et al. Among authors: babalola cp. Eur J Pharm Sci. 1999 Dec;9(2):131-6. doi: 10.1016/s0928-0987(99)00053-6. Eur J Pharm Sci. 1999. PMID: 10620725

7

Polymorphic oxidative metabolism of proguanil in a Nigerian population.

Bolaji OO, Sadare IO, Babalola CP, Ogunbona FA. Bolaji OO, et al. Among authors: babalola cp. Eur J Clin Pharmacol. 2002 Nov;58(8):543-5. doi: 10.1007/s00228-002-0509-7. Epub 2002 Sep 24. Eur J Clin Pharmacol. 2002. PMID: 12451432

8

Absolute bioavailability of quinine formulations in Nigeria.

Babalola CP, Bolaji OO, Ogunbona FA, Ezeomah E. Babalola CP, et al. Afr J Med Med Sci. 2004 Sep;33(3):185-9. Afr J Med Med Sci. 2004. PMID: 15819461 Clinical Trial.

9

Significant Pharmacokinetic Interactions Between Quinine and Ampicillin-Cloxacillin Combination.

Falade OB, Falusi AG, Olaniyi AA, Ezeasor C, Kwasi DA, Babalola CP. Falade OB, et al. Among authors: babalola cp. Drugs R D. 2016 Jun;16(2):193-203. doi: 10.1007/s40268-016-0128-x. Drugs R D. 2016. PMID: 27020278 Free PMC article. Clinical Trial.

10

Non-compartmental and population pharmacokinetic analysis of dapsone in healthy NIGERIANS: A pilot study.

Kotila OA, Ajayi DT, Masimirembwa C, Thelingwani R, Odetunde A, Falusi AG, Babalola CP. Kotila OA, et al. Among authors: babalola cp. Br J Clin Pharmacol. 2023 Nov;89(11):3454-3459. doi: 10.1111/bcp.15862. Epub 2023 Aug 15. Br J Clin Pharmacol. 2023. PMID: 37489004 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

60 results

Search Page

Filters